Scientists at Duke University Medical Center may have solved the mystery surrounding the healing properties of gold – a discovery they say may renew interest in gold salts as a treatment for rheumatoid arthritis and other inflammatory diseases.
Physicians first used injections of gold salts in the early 1900s to ease the pain and swelling associated with arthritis. But treatment came at a high cost: The shots took months to take effect and side effects included rashes, mouth sores, kidney damage and occasionally, problems with the bone marrow’s ability to make new blood cells. Recently, new treatments like methotrexate and biologically engineered drugs have replaced gold as a preferred treatment, and gold salts, while remaining effective, are usually administered as a last resort.
But Dr. David Pisetsky, chief of the division of rheumatology and immunology in the department of medicine at Duke, says “we shouldn’t dismiss gold salts so quickly. We scientists have really never understood why gold works. Now that we have a better handle on its action, we may be able to use that mechanism to create new and better gold-like drugs to treat arthritis.”
Pisetsky had long been interested in a particular molecule, HMBG1, which provokes inflammation, the key process underlying the development of rheumatoid arthritis. HMBG1 is a dual-function molecule, which means that it behaves one way when it’s inside the nucleus of a cell, and quite another way when it’s released from the cell.
Pisetsky says that inside the nucleus, HMGB1 is a key player in transcription, the process that converts genetic information in DNA to its RNA equivalent. But when HMGB1 is released from the cell – either through normal processes or cell death – it becomes a stimulus to the immune system and enhances inflammation.
“Interestingly, HMGB1 is not produced evenly throughout the body,” says Pisetsky.
“There is an unusually high amount of it in the synovial tissue and fluid around the joints – where arthritis occurs.”
Pisetsky, working with colleagues at the University of Pittsburgh and the Karolinska Institute in Sweden, stimulated mouse and human immune system cells to secrete HMGB1, then treated them with gold salts. They found that the gold blocked the release of HMGB1 from the nucleus. That, in turn, should lessen the amount available to provoke the body’s immune system, weakening the inflammatory response.
“Basically, keeping HMGB1 corralled inside the nucleus is a good thing, when it comes to arthritis,” says Pisetsky.
Pisetsky says gold inhibits the release of HMGB1 by interfering with the activity of two helper molecules that ease HMGB1’s release from the cell, interferon beta and nitric oxide.
The study will appear in the January, 2008 issue of the
Journal of Leukocyte Biology, but a preprint is already online at the journal’s website at:
http://tinyurl.com/3cd957.
“Now that we have identified at least one of the ways gold can help arthritis sufferers, perhaps we can use that knowledge to build new and safer-acting, gold-based treatments,” says Pisetsky, a senior author of the study.
Pisetsky is encouraged by the results but says additional studies need to be done to find out if the same mechanism is active in animals and people and not just in laboratory studies.
Source: Duke University
Related stories:
New test to diagnose osteoarthritis early
A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical Society. By far the most common form of arthritis, OA is a bane of the Baby Boom generation, causing joint pain and disability for more than half of those over 65 – nearly 21 million people in the United States.
Gold Nanoparticles Shine Brightly in Tumors
Solid gold nanoparticles have long been used to treat rheumatoid arthritis and more recently have shown promise in treating various types of cancer. Now, thanks to work by Shuming Nie, Ph.D., and his colleagues at the Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology, these same nanoparticles could serve as a powerful tumor-homing beacon for detecting microscopic tumors or even individual malignant cells. The researchers report their findings in the journal
Nature Biotechnology.
Gold nanoparticle probes may allow earlier cancer detection
Using tiny gold particles embedded with dyes, researchers have shown that they can identify tumors under the skin of a living animal. These tools may allow doctors to detect and diagnose cancer earlier and less invasively.
Pill that boosts productivity gaining favor, raising concerns among medical ethicists
In a place like Silicon Valley, where career prospects often hinge on a person's intelligence and ability to work hellishly long hours, "brain doping" probably was inevitable.
Scientists peel away the mystery behind gold's catalytic prowess
Few materials have exercised as much of a hold on the human imagination, or on human history, as has gold. But for all of its popular uses – money, medals, jewelry and more – gold's potential as a catalyst lay hidden until the 1980s, when Masatake Haruta and Graham Hutchings independently discovered that gold, which had long been considered inactive, could be an extraordinarily good catalyst. Haruta demonstrated the low-temperature oxidation of CO and Hutchings the hydrochlorination of acetylene to vinyl chloride.
Fish or fuel? Debate divides Norway's far north
The pristine Lofoten Islands off Norway's far north paint an idyllic image of tranquility, but beneath the surface is a roiling debate over the islands' resources, dividing fishermen, environmentalists and oil companies.
Parallel 'nano-soldering' technique chosen for year's top-50 by Nanotech Briefs
(PhysOrg.com) -- You should have so much patience to solder nanowires to nanoelectrodes. Talk about fine work. That’s why a new electroplating process that simultaneously joins many silicon nanowires to many prepatterned electrodes was selected for a 2008 Nano 50 Award by Nanotech Briefs.
Noninvasive test accurately identifies advanced liver disease without biopsy
Non-invasively measuring liver stiffness with transient elastography accurately diagnoses patients with late-stage liver disease, reports a new study in
Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.